Eli Lilly launches higher doses of Zepbound, lowers price of certain vials Lilly also said they have "long been concerned" about counterfeit, compounded and any unapproved tirzepatide in the ...

Eli Lilly is suing two pharmacies for compounding Zepbound and Mounjaro, claiming the companies are skirting the Food and Drug Administration's ban on the practice and luring people away from ...

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk for a much-awaited entry into the world's most populous country grappling ...

Eli Lilly (LLY) launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk (NVO) for a much-awaited entry into the world’s most populous ...

Eli Lilly weight loss drug: Eli Lilly launches Mounjaro, the much-awaited diabetes drug, in India. It is priced at ₹3,500 for 2.5 mg. (Representative Image) Eli Lilly weight loss drug ...

Eli Lilly and Co. is suing an Indianapolis ... the main ingredient in Mounjaro and Zepbound. Since 2023, Lilly has taken action against dozens of pharmacies, weight-loss centers and health spas ...